Related Experiment Video
Updated: Jul 13, 2026
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
[Percutaneous therapies for aortic and mitral valvular disease]
1Institut de cardiologie de Montréal, 5000 Rue Bélanger, Montréal. stephane.noble@hcuge.ch
Revue Medicale Suisse
|July 25, 2007
Summary
Percutaneous therapies for valvular heart disease, including aortic stenosis and mitral valve disease, show promising preliminary results. These minimally invasive procedures offer new options for patients with high surgical risks.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Context:
- Valvular heart disease management presents challenges, particularly in elderly patients with aortic stenosis.
- High surgical risks limit treatment options for a significant portion of affected individuals.
- Percutaneous approaches are emerging as alternatives to traditional surgery.
Purpose:
- To review the current status and preliminary outcomes of percutaneous therapies for valvular heart disease.
- To highlight advancements in percutaneous aortic valve replacement and mitral valve interventions.
- To discuss the potential and limitations of these novel treatment modalities.
Summary:
- The first percutaneous aortic valve bioprosthesis was implanted in 2002, with hundreds of procedures now performed using devices like Cribier-Edwards and Corevalve.
- Preliminary results for percutaneous aortic valve interventions are encouraging.
- Percutaneous mitral valve interventions, while less developed, show potential for specific conditions like stenosis, though mitral insufficiency remains complex.
Impact:
- Percutaneous therapies offer less invasive treatment options for valvular heart disease.
- These advancements may expand treatment access for elderly patients and those with high surgical risk.
- Continued development in percutaneous mitral valve interventions could address complex mitral valve pathologies.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...